Search

everythinglearnresearchcommunity

for

Search:↓

Combining low-level laser therapy with minoxidil doesn't improve hair loss treatment compared to using minoxidil alone.

Fractional laser therapy is a promising, effective, and minimally invasive treatment for hair loss.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Platelet-rich plasma injections effectively increase hair density in men suffering from common hair loss.

Treating vitiligo with stem cells and melanocytes from hair, along with UVB light, works better than without the light.

Low-level laser therapy is effective and safe for treating hair loss.

The study concluded that hirsutism is most common in women aged 14 to 48, often caused by PCOS, and can be effectively treated with Nd YAG laser and IPL.

Platelet-rich plasma mesotherapy improved symptoms in patients with corticosteroid-induced rosacea-like dermatitis.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Combining eflornithine cream with laser treatment removes facial hair better than laser alone.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

New methods for skin and nerve regeneration can improve healing and feeling after burns.

A weight loss program with a special fast helped patients lose an average of 41-47 pounds and improved their health, but maintaining the weight loss was challenging.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Injecting platelet-rich plasma during hair transplant surgery improves hair regrowth rate, speeds up skin recovery, and enhances hair quality.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Antimicrobial therapy can help manage Folliculitis Decalvans.

Semaglutide helps obese PCOS patients lose weight and improve health.

New compounds may soon be tested to treat excessive hair growth in women.

Nanoparticles can effectively treat diseases by modifying blood vessel growth.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Oral isotretinoin, especially at higher doses for at least 3 months, is effective for treating folliculitis decalvans.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Tailor treatments for vitiligo to patient needs for best results.